Praxis Precision Medicines, Inc. PRAX Business Segments — Other segment expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s business segments — other segment expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s business segments — other segment expenses?
- Praxis Precision Medicines, Inc. (PRAX) reported business segments — other segment expenses of $12.09M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s business segments — other segment expenses changed year-over-year?
- Praxis Precision Medicines, Inc.'s business segments — other segment expenses increased by 44.3% year-over-year, from $8.38M to $12.09M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s business segments — other segment expenses?
- Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s business segments — other segment expenses has grown at a 24.3% compound annual growth rate (CAGR), from $18.99M to $29.33M.
- What does business segments — other segment expenses mean?
- This metric captures miscellaneous operational costs within the business segment that are not classified as personnel, stock-based compensation, or depreciation. It typically includes facility overhead, third-party research services, and general administrative costs. It provides visibility into the 'burn rate' of the segment's day-to-day activities.